Mail

UK Markets closed

FTSE 100
7,405.45
-94.15(-1.26%)
FTSE 250
18,493.83
-236.13(-1.26%)
AIM
800.42
-7.02(-0.87%)
GBP/EUR
1.1363
+0.0026(+0.22%)
GBP/USD
1.2230
-0.0058(-0.4745%)
BTC-GBP
22,450.23
-664.38(-2.87%)

Luxurious new rental properties to put on your radar

Build to rent developers are making flats that look like hotels

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

24.18

-0.30

(-1.23%)

At close: 04:00PM EDT

24.02

-0.16

(-0.66%)

After hours:

07:58PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.86
52-week change ³	N/A
S&P500 52-week change ³	N/A
52-week high ³	77.72
52-week low ³	23.22
50-day moving average ³	29.18
200-day moving average ³	42.32

Share statistics

Avg vol (3-month) ³	2.04M
Avg vol (10-day) ³	2.39M
Shares outstanding ⁵	102.44M
Implied shares outstanding ⁶	N/A
Float ⁸	97.59M
% held by insiders ¹	4.68%
% held by institutions ¹	93.57%
Shares short (30 Jan 2023) ⁴	5.53M
Short ratio (30 Jan 2023) ⁴	3.52
Short % of float (30 Jan 2023) ⁴	7.29%
Short % of shares outstanding (30 Jan 2023) ⁴	5.40%
Shares short (prior month 29 Dec 2022) ⁴	5.1M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	N/A
Trailing annual dividend yield ³	N/A
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2021
Most-recent quarter (mrq)	29 Sept 2022

Profitability

Profit margin	-140.58%
Operating margin (ttm)	-114.71%

Management effectiveness

Return on assets (ttm)	-15.73%
Return on equity (ttm)	-125.48%

Income statement

Revenue (ttm)	430.76M
Revenue per share (ttm)	4.22
Quarterly revenue growth (yoy)	23.90%
Gross profit (ttm)	250.74M
EBITDA	-462.23M
Net income avi to common (ttm)	-605.56M
Diluted EPS (ttm)	-2.60
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	958.04M
Total cash per share (mrq)	9.35
Total debt (mrq)	1.37B
Total debt/equity (mrq)	823.66
Current ratio (mrq)	6.46
Book value per share (mrq)	12.96

Cash flow statement

Operating cash flow (ttm)	-295.7M
Levered free cash flow (ttm)	-275.02M